ID   C2-Rev 7
AC   CVCL_3361
SY   C2-Rev7; C2-rev7
DR   CLO; CLO_0002110
DR   CLDB; cl561
DR   CLDB; cl560
DR   ECACC; 94101907
DR   ICLC; ATL96007
DR   Wikidata; Q54807890
RX   PubMed=2956094;
RX   PubMed=6247070;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4722 ! Faof1C2
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
RX   PubMed=2956094; DOI=10.1002/j.1460-2075.1987.tb02424.x;
RA   Friedman J.M., Babiss L.E., Weiss M., Darnell J.E. Jr.;
RT   "Hepatoma variants (C2) are defective for transcriptional and
RT   post-transcriptional actions from both endogenous and viral genomes.";
RL   EMBO J. 6:1727-1731(1987).
//
RX   PubMed=6247070; DOI=10.1016/0092-8674(80)90095-1;
RA   Deschatrette J., Moore E.E., Dubois M., Weiss M.C.;
RT   "Dedifferentiated variants of a rat hepatoma: reversion analysis.";
RL   Cell 19:1043-1051(1980).
//